C-V6FYOmniscope
immunosequencing, TCR/BCR analysis, generative AI
diagnostics
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-V6FY
C-V6FYC-V6FYimmunosequencing, TCR/BCR analysis, generative AI
0-100 chain-logic scale · 15 dimensions · scored on public evidence
In a world competing for people’s time and trust, digital experiences need to be thoughtfully designed to create lasting impact. How do we help people stick to their goals, build healthier habits, and drive meaningful outcomes in healthcare? We partnered with the British Consulate-General Boston to explore how AI, digital coaching, personalisation, and data-driven insights are redefining patient care. Our incredible panel shared what’s working; from tackling adherence challenges to designing experiences that keep people coming back. Read more about the key takeaways from the event here: https://ustwo.com/blog/how-to-create-digital-experiences-that-inspire-and-sustain-health-habits/ Panellists Lynnette Ang, Co-Founder & Chief Growth Officer of Omniscope Greig Robinson, Head of Design at ustwo Shikha Anand, Co-founder of Zeph Technologies Moderator: Heidi Legg, writer and journalist 00:00:00 Introduction 00:02:30 Exciting features of AI & Health 00:14:50 Large data sets 00:19:00 Des
Watch the full discussion here: https://youtu.be/aijoqkgm_SI Read more on our blog: https://ustwo.com/blog/how-to-create-digital-experiences-that-inspire-and-sustain-health-habits/ In a world competing for people’s time and trust, digital experiences need to be thoughtfully designed to create lasting impact. How do we help people stick to their goals, build healthier habits, and drive meaningful outcomes in healthcare? Panellists Lynnette Ang, Co-Founder & Chief Growth Officer of Omniscope Greig Robinson, Head of Design at ustwo Shikha Anand, Co-founder of Zeph Technologies Moderator: Heidi Legg, writer and journalist
Startup Festival: Diagnostic Tools in Today's Healthcare Environment. Featuring Dr. Holger Heyn and Lynnette Ang, co-founders of Omniscope. Credits: Start in Malta (https://startinmalta.com)
Publications from Omniscope Home Pharma Sports Lifetime Learn Publications Recordings News Contact Log in Immune Portal osSports osLifetime English Español Log in Immune Portal osSports osLifetime Publications Read the latest publications involving Omniscope Paper Interpretable Inflammation Landscape of Circulating Immune cells Laura Jiménez-Gracia, et al. January 22, 2026 Scientific poster October 21, 2025 An actionable Immune Age model of T cell activity and aging Ana Mendizabal-Sasieta, Umberto Perron, Dmytro Pravdyvets, Juan L. Melero, Marta Grzelak, Marta Soto, Mariana Capelli, Matthew Sa … zelak, Marta Soto, Mariana Capelli, Xavier Yanguas, Gil Rodas Font, Holger Heyn Application note April 3, 2025 osLifetime - Your legacy, Elevated Paper February 28, 2025 STAMP: Single-Cell Transcriptomics Analysis and Multimodal Profiling through Imaging Emanuele Pitino, Anna Pascual-Reguant, Felipe Segato-Dezem, Kellie Wise, Irepan Salvador-Martinez, Helena Lucia Crowell, Elise Courtois8, William F. Flynn, Santhosh Sivajothi, Emily Soja, Sara Ruiz, Ginevra Caratù, Adrienne E … mmer, Holger Heyn, Luciano Martelotto https://doi.org/10.1101/2024.10.03.616013 Application note February 27, 2025 osSports - Elevate Your Game Paper January 6, 2025 Linking tumor immune infiltration to enhanced longevity in recurrence-free breast cancer L. Angelats, L. Paré, C. Rubio-Perez, E. Sanfeliu, A. González, E. Seguí, G. Villacampa, M. Marín-Aguilera, S. Pernas, B. Conte, V. Albarrán-Fernández, O. Martínez-Sáez, Á. Aguirre, P. Galván, A. Fernandez-Martinez, S. Cobo, … oz Perez, Raquel Arnau Galan, Juan C. Nieto, Alexandra Avgustinova, Holger Heyn Application note November 1, 2024 Deep immune profiling to accelerate vaccine development Scientific poster September 13, 2024 Liquid biopsy tracking of immunotherapy-induced T cell dynamics in MSS colorectal and endometrial tumors Holger Heyn, Juan Luis Melero, Gerard Deuner, Iosune Baraibar, Marta Grzelak, Ginevra Caratú, Carmen García-Durán, Francisco Grau, David García-Illescas, Lorena Fariñas … ena Gros, Josep Tabernero, Ana Oaknin, Juan Nieto, Nick Borcherding, Elena Élez Application note July 1, 2024 Immune sequencing: A paradigm shift in deciphering small fiber neuropathy Application note June 1, 2024 Harnessing the immune system to chart therapy response Scientific poster May 27, 2024 Deciphering clonal expansion and the immune land
Vijay Vaswani | Co-Founder & CEO at Omniscope Molecule to Market is proudly sponsored by Bora Pharmaceuticals - The premium CDMO partner Home Episodes About Be a guest Memoirs Get in touch Vijay Vaswani Omniscope Episode 179 AI as a force for good in drug development Listen to podcast 52:04 In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Vijay Vaswani , Co-Founder & CEO at Omniscope . Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Vijay, covering: How travel expands the m … he biotechnology industry and finds his passion in improving health through the application of technology. Please subscribe, tell your industry colleagues, and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating! Molecule to Market is sponsored and funded by ramarketing , an international marketing, design, digital, and content agency helping companies differentiate, get notic
Omniscope Home Pharma Sports Lifetime Learn Publications Recordings News Contact Log in Immune Portal osSports osLifetime English Español Log in Immune Portal osSports osLifetime See what your immune system is seeing. Explore your immune system to boost performance optimize healthspan engineer therapy Lifetime DISCOVER Sports DISCOVER Pharma DISCOVER Latest news View all Bridging the Gap Between Research and Impact in Barcelona April 29, 2026 Omniscope and barnaclínic+ Launch AI-Driven Immune Decoding to Redefine Sports Medicine April 22, 2026 AYUN and Omniscope Launch AI-Driven "Cellular
Buenavista Equity Partners Announces Strategic Investment in Omniscope - Capital-Riesgo.es Articles Directory My Account Contact Go Buenavista Equity Partners Announces Strategic Investment in Omniscope Home / Articles / Private Equity Investors in Health and Medical sector Private Equity Investors in Technology , Private Equity Investors in Health and Medical sector Buenavista Equity Partners, a private equity group specialising in the lower/mid-market segment in Spain, announced today its strategic investment in Omniscope, a fast-growing technology company at the crossroads of biotechnology … sonalized medicine. The investment, carried out through the Buenavista Ventures fund, is set to accelerate Omniscope’s growth, supporting its mission to simplify complex data for organizations of all sizes. Omniscope’s platform is already transforming how industries—from healthcare to retail—leverage data to drive decisions and create value. “We are thrilled to partner with Omniscope and its visionary co-founders, Vijay, Holger and Lynnette, whose leadership and technical exp
%PDF-1.7 %���� 79 0 obj > endobj 82 0 obj > stream H���yTSw�oɞ����c [���5la� QIBH�ADED���2�mtFOE�.�c��}���0��8��8G�Ng��� ��9�w���߽����'����0 �֠�J��b� 2y�.-;!���K�Z� ���^�i�"L��0���-�� @8(��r�;q��7�L��y��&�Q��q�4�j���|�9�� �V��)g�B�0�i�W��8#�8wթ��8_�٥ʨQ����Q�j@�&�A)/��g�>'K���t�;\�� ӥ$պF�ZUn��� �(4T�%)뫔�0C&�����Z��i���8��bx��E���B �;�����P���ӓ̹�A� om?�W= �x������-�����[���0� ���}��y)7ta�����>j���T�7���@���tܛ�`q�2��ʀ��&���6�Z�L�Ą? �_ ��yxg)˔z���çL�U���*�u�Sk�Se�O4?�c����.�� ��R� ߁��-��2�5������ ��S�>ӣV����d�`r��n~��Y�&�+`��;�A4�� … M��2�^� KxfN�����~� N� �G,��"P��>o��� ?4N�X�}UC��U� b�5_��������kD�_YjH�rFp`(0�����5�>�2��*�!! `�*,ʃL�-����P�۞)�C�XU�܃�x��+^[f�:�2�r�x�_��;3�A 鸛��]�2� r�sO� ᘿ_JK��� ?�6���k��d�&�р�X�ѐ*#����E��5}��~�4)��r�9x'�7|g� C��T���H�s���� J�X Y�!�(���[M��}��2�,�h�/�����˗����������ן��O�XUm�*/�����f���>�HNX�� ��O�!.�뼍��2M�"�*w�&�ߎe� ��|9�����(,�& 9����7��qt��� ���\�+ � w�{*���Bp� �S"�FWF�k�U� _�'�S�� �6rx�B,� (ܿ~#��̌`���5K]@��Z�lm�98vhJ�+�(
Fox Chase Cancer Center and Omniscope Announce Research Collaboration to Advance Non-Small Cell Lung Cancer Immunotherapy Development | Fox Chase Cancer Center - Philadelphia PA Skip to main content Utility Nav About Us Blog History Administrative Leaders Clinical Leaders Research Leaders External Advisory Board Administrative Offices Care Connect News & Publications Events International Partners Careers Locations Contact Us Giving Patient Portal Katz School of Medicine Utility Nav 2 Find a Doctor Request Appointment 888-369-2427 Main navigation Clinical Care About Fox Chase Cancer Center
Omniscope to present at Techbio Showcase™ 2025 Home Pharma Sports Lifetime Learn Publications Recordings News Contact Log in Immune Portal osSports osLifetime English Español Log in Immune Portal osSports osLifetime Back to News Company News Omniscope to present at Techbio Showcase™ 2025 Omniscope’s high-resolution immune data powers collaboration with the Barça Innovation Hub, debuting an Early Access athletic performance platform. Lynnette Ang January 2, 2025 1 min DELAWARE, USA - 02 January 2025 – Omniscope Inc., today announced that it is presenting at TechBio Showcase, part of Biotech Sho
Omniscope Joins NVIDIA Inception Home Pharma Sports Lifetime Learn Publications Recordings News Contact Log in Immune Portal osSports osLifetime English Español Log in Immune Portal osSports osLifetime Back to News Company News Omniscope Joins NVIDIA Inception Building the world's largest and most complete immune databank. Lynnette Ang February 5, 2024 1 min BARCELONA, SPAIN - 05 February 2024 - Omniscope Inc. today announced it has joined NVIDIA Inception, a program that nurtures startups revolutionizing industries with technological advancements. Omniscope is focused on building the w
Omniscope News Home Pharma Sports Lifetime Learn Publications Recordings News Contact Log in Immune Portal osSports osLifetime English Español Log in Immune Portal osSports osLifetime Omniscope News Bridging the Gap Between Research and Impact in Barcelona April 29, 2026 Omniscope and barnaclínic+ Launch AI-Driven Immune Decoding to Redefine Sports Medicine April 22, 2026 AYUN and Omniscope Launch AI-Driven "Cellular Avatars" to Redefine Longevity April 18, 2026 RAFA Racing Club partners with Omniscope to unlock immune performance at Daytona January 20, 2026 Omniscope and Fox Chase C
#scienceisweall #precisiononcology | Omniscope LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement , Privacy Policy , and C
Recordings from Omniscope Home Pharma Sports Lifetime Learn Publications Recordings News Contact Log in Immune Portal osSports osLifetime English Español Log in Immune Portal osSports osLifetime Recordings Watch Omniscope in action. NEXT Omniscope and barnaclínic+ Launch AI-Driven Immune Decoding to Redefine Sports Medicine Omniscope decodes immune data to personalize performance and recovery strategies for athletes. Partnering with barnaclínic+, we’re delivering these insights to active individuals while supporting public healthcare. BBC Sport & Omniscope: The Biological Revolution Redefi … Vijay Vaswani discusses Omniscope's osLifetime platform, highlighting its application to monitor longevity interventions. The Immune System as a Natural Sensor for Health and Aging At the Biology of Aging Conference (GRC), CSO and Cofounder Holger Heyn discusses Omniscope's osLifetime platform, highlighting its application to monitor health and aging. Receive updates from Omniscope OVERVIEW Sports Lifetime Pharma Projects Publications COMPANY About us News Careers
Omniscope at ARDD 2025: Decoding the Immune System for Healthspan Home Pharma Sports Lifetime Learn Publications Recordings News Contact Log in Immune Portal osSports osLifetime English Español Log in Immune Portal osSports osLifetime Back to Recordings Recordings August 26, 2025 Omniscope at ARDD 2025: Decoding the Immune System for Healthspan At the 12th Aging Research & Drug Discovery Meeting, CEO and Cofounder Vijay Vaswani discusses Omniscope's osLifetime platform, highlighting its application to monitor longevity interventions. Receive updates from Omniscope OVERVIEW Sports Life
#mwc #4yfn #startups #scaleups #innovation #technology | Tomas Pulido LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement ,
Exhibitor Profile - PMWC Precision Medicine World Conference Chat with us , powered by LiveChat Skip to content Chats Contact Speakers Agenda Tickets Menu FULL MENU FULL MENU Register here Rates by JUL. 2 Register here PMWC, Jan 25-27, 2023 PMWC - Silicon valley, ca January 27-29, 2027 Past Event PMWC, Feb 5-7, 2025 PMWC - Silicon valley, ca January 27-29, 2027 Attend Program Schedule Sessions Honorees Speakers Company Competition Showcases Travel Venue Sightseeing Reduced Rates Hotel Flights Exhibits + Map Login / My Account Participate REGISTER TO EXHIBIT Prospectus Attendee Breakdown Apply … ogin / My Account Participate Register to Exhibit Prospectus Attendee Breakdown Apply to speak Sponsorship Inquiry GET UPDATES ABOUT Mission Testimonial Past Conferences Past Honorees Past Speakers FAQ CONTACT US Menu agenda speakers exhibits Contact us agenda speakers exhibits Contact us BUY TICKETS SAVE $1351 BY JUL. 2 Menu Item #1 Item #1 PMWC - Silicon valley, ca Jan. 27-29, 2027 Pittsburgh, pa sep. 23-24 PMWC - Silicon valley, ca Jan. 27-29, 2027 Register Here Rates by J … tend Program Speakers Travel Exhibits + Map Main Program View your save program Award Reception Speaker gallery Select part speakers Exhibit gallery Part conferences Participate Register to Exhibit Apply to speak Sponsorship Inquiry ABOUT Login / My Account CONTACT US Get Updates Pittsburgh, pa sep. 23-24 Register Here Rates by Attend Program Travel Reduced Rates Exhibits + Map Main Program View your save program Award Reception Paticipate Register to Exibit Apply to speak Sp … nomix Labs Alphaexpeditions Alpine Alquest Therapeutics ALS Emergency Treatment Fund Alta Bates Summit Comprehensive Cancer Center Alta Devices AltaQ Altered Egos Comics AltheaDx Althia Altiora Altis Biosystems, LLC Altoida Inc Altos Labs AltruBio Altum Medical Alum Alumot – sprint Aluna Health Alva10 Alveo Technologies Alverno Laboratories AlwaysRx Alykomed Global Solutions LLC Alykomedglobal Alzheimer’s X Alzheon AMA Ama-Assn Amaro Therapeutics Amazon Amber Health Amb … Y Ancestry Anderson Cancer Center Andreessen Horowitz Andrew Andy Strouse Angel Fund Angel Investor ANGLE Biosciences ANGLE Europe Ltd. ANGLE, plc Angleplc Angstrom Bio Angular Medicine Anima AnjaGen Consulting Anl Annai Systems, Inc Annexon Biosciences Annexon Inc Annexonbio Anocca Ansun Biopharma Antenna Anthem Anthony Pastena, M.D. ,P.C Anthos
12 startups tackling cancer to watch, according to VCs | Sifted Analysis May 12, 2023 12 startups tackling cancer to watch, according to VCs VCs from Verve Ventures, MMC Ventures, HTGF and Sofinnova Partners shared their picks Kai Nicol-Schwarz 5 min read Share Funding for startups tackling cancer might have dipped since the highs of 2020 and 2021 — when $2.3bn was pumped into the sector each year — but startups are still raising sizeable cheques. So far this year, the biggest raises in the sector have been: France-based Amolyt Pharma’s $138m Series C UK-based GreyWolf Therapeutics’ $49m Serie … atform and disease-specific data libraries. Moving forward, the company will be rolling out different products in immunotherapy (OS-IMT) and patient monitoring (OS-MRD) across different types of cancer. Charlotte Barttelot, principal at MMC Ventures MMC Ventures is a London-based seed and Series A-focused VC. Turbine — Hungary Founded in 2016, Turbine is leveraging AI-powered technology to understand oncology patients by simulating cells. Its simulation platform can model how … ovable and how startups can partner with the tech giant News EIF launches €15bn fund of funds to back 100 growth-stage VCs Kai Nicol-Schwarz Kai Nicol-Schwarz was a senior reporter at Sifted. He covered AI and UK tech. # Healthtech # Investor survey Sifted Daily newsletter Weekdays Stay one step ahead with news and experts analysis on what’s happening across startup Europe. Sign up for free Recommended Health unicorn Alan raises €480m Series G round led by Prosus Fresh fundin
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Portfolio - Companies in which Namarel has invested Skip to content About us Investment strategy Portfolio News and Events Contact us EN EN ES Portfolio Home » Portfolio Namarel is committed to companies that contribute to improving people’s quality of life. Magentiq Eye Leading the Endoscopy AI transformation, starting with Gastroenterology. www.magentiq.com Mimark At MiMARK we are developing innovative in vitro diagnostic solutions to improve the treatment of gynecological malignancies. www.mimark.es Elem ELEM creates populations of virtual humans to predict the outcome of pharmacologi … Are you developing a disruptive technology with an impact on the health sector? Submit your pitch Submit Barcelona based About us Investment strategy Portfolio News and Events Contact us We drive disruptive innovation to solve health challenges with an impact on people. © Namarel Ventures 2026 Legal notice · Privacy policy · Cookies policy · by Pukkas Legal notice · Privacy policy Cookies policy · by Pukkas About us Investment strategy Portfolio News and Events Contact us EN
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Concurrent Workflow jobs execution : Omniscope Help Center Skip to main content Omniscope Help Center Home Knowledge base Forums Submit a ticket Login Sign up Home Knowledge base Omniscope Workflow app ... Knowledge base Omniscope Workflow app Concurrent Workflow jobs execution All Articles Topics Recent Searches Clear all No recent searches Popular Articles Articles View all Topics View all Tickets View all Sorry! nothing found for Concurrent Workflow jobs execution Modified on Tue, 16 Mar, 2021 at 8:21 PM This article describes how to run multiple Workflow jobs at the same time, understand r
Omniscope Company Overview, Contact Details & Competitors | LeadIQ Learn more at LeadIQ.com Start free Insights Similar companies Tech Stack Media & News Email Format FAQ Insights Innovative Technology Omniscope leverages advanced immune cell sequencing combined with artificial intelligence to develop diagnostics and therapies, positioning itself as a leader in precision healthcare solutions that can be tailored for specialized medical institutions and diagnostics providers. Strategic Collaborations The company's recent partnerships with Fox Chase Cancer Center, Ayun Ag, and RAFA R
MaltaCEOs.mt - AI-enabled biotech company OmniScope has... Facebook Log In MaltaCEOs.mt's Post MaltaCEOs.mt May 18, 2021 · Shared with Public AI-enabled biotech company OmniScope has announced the start of research and development of a medical diagnostics tool for COVID-19 in Malta, facilitated by the financial support of €1 million from Malta Enterprise maltaceos.mt Malta to play ‘central role’ in groundbreaking medical diagnostics research – OmniScope co-founders All reactions: 6 3 shares Like Comment
Omniscope Inc. Asset Profile | Preqin Skip to main content Products Our products Preqin Pro Alternative assets data platform Private Markets Research Industry research Term Intelligence Benchmark LPA terms Preqin Benchmarks Industry's leading performance data Preqin Sustainability ESG data and insights Company Intelligence Companies & deals data Enterprise Data Solutions Flexible data delivery solutions Transaction Intelligence A $5.4tn transaction repository Client stories What our clients say Quick Links Our data Asset classes we cover Create a free account Newsletter Contribute dat … r analysis Keep up with market trends Spot new business opportunities Benchmark fund terms Navigate private credit investing Quick Links Our data Asset classes we cover Create a free account Newsletter Contribute data Contact us Insights+ Private markets research Homepage Browse reports Search Search the research library Webinar recordings Join conversations with our analysts Meet the analysts Meet the team behind the reports Learn more Learn more about Private Markets Resear … r analysis Keep up with market trends Spot new business opportunities Benchmark fund terms Navigate private credit investing Insights+ Homepage Search Webinar recordings Meet the analysts Learn more News & content Homepage Events Free Benchmarks Data coverage map Preqin Profiles Preqin Academy Compensation calculator About Who we are Our corporate responsibility Partners Press hub Careers Contact us QuickLinks Our data Asset classes we cover Create a free account Newslett … ed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers. Request demo Omniscope Inc. - overview Established 2021 Location Dover, DE, US Primary Industry Biotechnology About Based in the US, Omniscope empowers athletes through advanced technology for immune analysis and diagnostics, enhancing personalized healthcare solutions. Founded in 2021 and headquartered in Dover, US, O … go Pro Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more. Sign in Request demo Our Company Who We Are Our Corporate Responsibility Partners
Vijay Vaswani, CEO and Co-founder of Omniscope, is on a mission to crack the "immune code" - the intricate system that governs the human adaptive immune response. 🧬 Omniscope was established by a… | Imperial Global USA LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update y … s of OMOP integration. Her perspective resonated so strongly that I was able to apply one of her insights to our ADHD-related project this week - a real example of learning translating into practice! I’m grateful for the chance to meet so many passionate professionals, leaders, and researchers who are advancing the field of precision medicine. https://lnkd.in/gAZiEH2A WIN Symposium Advancing Precision Medicine #precisionmedicine #APM #data #RWD 158 Like Comment Share Copy Lin … or add a comment, sign in Panda Yu 8mo Report this post To #promote the #rapid #application of #big model technology in various #medical and #health scenarios, VCBeat Health has specially organized a series of live streaming activities on the theme of "AI for Life". This event will be conducted in the form of an online live conference, inviting 3-4 leading domestic enterprises and industry experts in the field of large models for each session, focusing on a single large model … in the field of large models for each session, focusing on a single large model application scenario for in-depth dialogue, in order to solve landing problems, link ecological resources, and promote more ecological cooperation and supply-demand docking. Since this year, from pancreatic cancer to breast cancer, to prostate cancer, liver cancer and other cancers, from interrogation to diagnosis to full course management of single cancer, the development of domestic cancer (tumo
Buenavista Equity Partners Announces Strategic Investment in Omniscope - Buenavista Equity Partners Ir al contenido The firm Investment Areas Private Equity Real Assets – Infrastructure Buenavista Ventures Portfolio Team Sustainability ESG commitment Transparency Responsible investment Best practices Sustainability Policy of Portugal Contact News en es The firm Investment Areas Private Equity Real Assets – Infrastructure Buenavista Ventures Portfolio Team Sustainability ESG commitment Transparency Responsible investment Best practices Sustainability Policy of Portugal Contact News The firm Cor … sonalized medicine. The investment, carried out through the Buenavista Ventures fund, is set to accelerate Omniscope’s growth, supporting its mission to simplify complex data for organizations of all sizes. Omniscope’s platform is already transforming how industries—from healthcare to retail—leverage data to drive decisions and create value. “We are thrilled to partner with Omniscope and its visionary co-founders, Vijay, Holger and Lynnette, whose leadership and technical exp … d investment company, has invested in Buenavista Buyout Innvierte III España, a fund specialising in investments in Spanish companies with strong growth and international expansion potential 25 May 2026 SOKAI secures €64.5 million in funding to develop its life sciences hub in San Sebastián 11 June 2026 Buenavista Equity Partners commits €7.9 million to sustainable tourism in Zarautz Ver todas Buenavista Equity Partners España Montalbán 7, 3ª planta Madrid, España +34 917 020
Vijay Vaswani - Omniscope | MWC Barcelona Skip to main content. Search Attend Why attend? MWC26 HIghlights 2026 Agenda 2026 Speakers 2026 Exhibitors Highlights About About Sponsors and Partners News Video Library Sustainability / Home / Speakers / Vijay Vaswani Vijay Vaswani Omniscope, Co-Founder & CEO Speaker Bio Vijay views technology as fundamental to humanity. He has been part of scaling companies such as Illumina and 10X Genomics. He has acquired and commercialized disruptive diagnostic technologies during his leadership at Siemens Healthineers and Meridian Biosciences. Vijay has been … he biotechnology industry and finds his passion in improving health through the application of technology. Related Sessions SPORTS TOMORROW CONGRESS 02/03/2026 • 09:45 - 18:45 CEST Hall 6, Lamarr Stage CORPORATE INNOVATION Physical Session Locations Lamarr Stage Themes CORPORATE INNOVATION Tracks Partner Programmes Interests CORPORATE INNOVATION CORPORATE INNOVATION CORPORATE VENTURING ENTREPRENEURSHIP HEALTH / FITNESS / WELLBEING IMPACT / SOCIAL INNOVATION INNOVATION E
Omniscope to present at Biotech Showcase™ 2024 Home Pharma Sports Lifetime Learn Publications Recordings News Contact Log in Immune Portal osSports osLifetime English Español Log in Immune Portal osSports osLifetime Back to News Company News Omniscope to present at Biotech Showcase™ 2024 Building the world's largest and most complete immune databank. Lynnette Ang December 5, 2023 1 min DELAWARE USA, 05 December 2023 – Omniscope Inc. today announced that it is presenting at Biotech Showcase™ 2024. This year, registered attendees can view Omniscope's presentation live, and also access
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
timeinpixels-nobe-omniscope-aja-integration - TM Broadcast International Magazine News Broadcasters Industry Voices Zoom In Explainer Test Area Newsletter Shopping cart No Widget Added Please add some widget in Offcanvs Sidebar Brompton Technology powers one of China’s largest virtual production facilities Magazine News Broadcasters Industry Voices Zoom In Explainer Test Area Newsletter Home AJA integrates Nobe OmniScope solution into its applications to provide in-depth information to color professionals timeinpixels-nobe-omniscope-aja-integration timeinpixels-nobe-omniscope-aja-integra
Pitchbook startup radar: European VCs on AI startups to watch Home Pharma Sports Lifetime Learn Publications Recordings News Contact Log in Immune Portal osSports osLifetime English Español Log in Immune Portal osSports osLifetime Back to News Company News Pitchbook startup radar: European VCs on AI startups to watch Omniscope mentioned as 1 of 12 startups. Lynnette Ang April 14, 2023 6 European VCs active in AI share 2 startups each - one in their portfolio, one not - that they think are worth highlighting. Perman Jorayev, VC investor, of Verve Ventures mentions Omniscope as one to watch: & … at different stages of disease progression. Moving forward, the company will be rolling out different products across vaccine development, immunotherapy and patient monitoring." More in the article at Pitchbook news. Receive updates from Omniscope OVERVIEW Sports Lifetime Pharma Projects Publications COMPANY About us News Careers FAQ Contact TERMS & POLICIES Privacy policy Other policies Cookie settings Social Media See what your immune system is seeing. Subscribe
Omniscope welcomes Dr. Josep M Piulats as newest Advisor Home Pharma Sports Lifetime Learn Publications Recordings News Contact Log in Immune Portal osSports osLifetime English Español Log in Immune Portal osSports osLifetime Back to News Company News Omniscope welcomes Dr. Josep M Piulats as newest Advisor Dr. Josep M Piulats joins Omniscope as Advisor. Omniscope News January 31, 2025 1 min Omniscope is delighted to announce Dr. Josep Maria Piulats Rodríguez as our newest advisor. Dr. Piulats serves as a Group Leader in Cancer Oncology at both the Bellvitge Biomedical Research Institute (IDIB
#newyorkbio #financesummit #biotechfinance #omniscopepartners #capitalstrategy #lifesciences | OmniScope Partners LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign
On the instrumentation of the Omniscope Skip to main content Log in (current) MIT Open Scholarship DSpace@MIT Search Home MIT Libraries MIT Theses Graduate Theses On the instrumentation of the Omniscope On the instrumentation of the Omniscope Download Name 757151443-MIT.pdf Description Full printable version Show more Size 10.51 MB Format Adobe PDF Checksum (MD5) b807cac2b1b016f5c6c6e3b929e9ebcc Author(s) Sánchez, Nevada J Advisor(s) Max Tegmark. Date Issued 2011 Publisher Massachusetts Institute of Technology Abstract An emergent technique known as 21-cm tomography has the potential to become
Omniscope - Executive Bio, Top Executies, and Transitions - Equilar ExecAtlas Request a Demo Win Deals Through Your Network Transform relationships with clients, colleagues, and partners into actionable insights. Search for an Executive Trusted by Trusted by Featured Organization Omniscope omniscope.ai Company Details Description TechBio company decoding the immune system in high resolution to inform therapy and develop diagnostics through the convergence of immune cell sequencing and artificial intelligence. For more information: https://www.omniscope.ai/immune-portal Industry Biotech & B … in the biotechnology industry and finds his passion in improving health by the application of technology. Read More Lynnette Ang Co-Founder & Chief Growth Officer Lynnette brings to Omniscope her experience in the financial sector , where she served a diverse client base at Aberdeen Asset Management. These spanned government, private and public financial institutions including Sovereign Wealth Funds, Global Pensions, Central Banks, Insurers as well as Independent interme … l Banks, Insurers as well as Independent intermediates, global banks and online fund platforms. Read More Prof. Holger Heyn PhD Co-Founder & Chief Scientific Officer Holger leads the Single Cell Genomics Group at the Spanish National Centre for Genomic Analysis (one of Europe’s largest Genome Centres). He has co-authored over 80 publications, and his research has received over €7.5m funding from (inter)national agencies. Dr. Holger is a key opinion leader in the field of … in the biotechnology industry and finds his passion in improving health by the application of technology. Read More Lynnette Ang Co-Founder & Chief Growth Officer Lynnette brings to Omniscope her experience in the financial sector , where she served a diverse client base at Aberdeen Asset Management. These spanned government, private and public financial institutions including Sovereign Wealth Funds, Global Pensions, Central Banks, Insurers as well as Independent interme … l Banks, Insurers as well as Independent intermediates, global banks and online fund platforms. Read More Prof. Holger Heyn PhD Co-Founder & Chief Scientific Officer Holger leads the Single Cell Genomics Group at the Spanish National Centre for Genomic Analysis (one of Europe’s largest Genome Centres). He has co-authored over 80 publications,
Sifted: 12 startups tackling cancer to watch, according to VCs Home Pharma Sports Lifetime Learn Publications Recordings News Contact Log in Immune Portal osSports osLifetime English Español Log in Immune Portal osSports osLifetime Back to News Company News Sifted: 12 startups tackling cancer to watch, according to VCs Omniscope mentioned as 1 of 12 startups. Lynnette Ang May 18, 2023 Venture Capitals from Verve Ventures, MMC Ventures, HTGF, and Sofinnova Partners share their cancer startup picks to keep an eye on going into the second half of 2023. Perman Jorayev, VC investor, of Verve Ventur … atform and disease-specific data libraries. Moving forward, the company will be rolling out different products in immunotherapy (OS-IMT) and patient monitoring (OS-MRD) across different types of cancer." More in the article at Sifted. Receive updates from Omniscope OVERVIEW Sports Lifetime Pharma Projects Publications COMPANY About us News Careers FAQ Contact TERMS & POLICIES Privacy policy Other policies Cookie settings Social Media See what your immune system is
Omniscope Skip to main content. Search Attend 2025 highlights Why attend Register your interest Conference col 1 2025 agenda 2025 speakers 2026 call for speakers 2026 themes Exhibition 2025 exhibitors Become an exhibitor in 2026 About About us Our journey Sponsors and Partners Ministerial Programme News Sponsor or Exhibit / Home / Exhibitors / Omniscope Omniscope Startup Location Exhibition Hall Stand 4Y3.7 Information Building the world's largest immune databank to inform therapy and develop diagnostics through a convergence of high-resolution immune cell sequencing and artificial intell
OmniScope-rs/LICENSE at master · Timwood0x10/OmniScope-rs · GitHub Skip to content Navigation Menu Toggle navigation Sign in Appearance settings Platform AI CODE CREATION GitHub Copilot Write better code with AI GitHub Copilot app Direct agents from issue to merge MCP Registry New Integrate external tools DEVELOPER WORKFLOWS Actions Automate any workflow Codespaces Instant dev environments Issues Plan and track work Code Review Manage code changes APPLICATION SECURITY GitHub Advanced Security Find and fix vulnerabilities Code security Secure your code as you build Secret protection Stop leaks … Trust center Partners View all resources Open Source COMMUNITY GitHub Sponsors Fund open source developers PROGRAMS Security Lab Maintainer Community Accelerator GitHub Stars Archive Program REPOSITORIES Topics Trending Collections Enterprise ENTERPRISE SOLUTIONS Enterprise platform AI-powered developer platform AVAILABLE ADD-ONS GitHub Advanced Security Enterprise-grade security features Copilot for Business Enterprise-grade AI features Premium Support Enterprise-grade 24/7 … our input very seriously. Include my email address so I can be contacted Cancel Submit feedback Saved searches Use saved searches to filter your results more quickly --> Name Query To see all available qualifiers, see our documentation . Cancel Create saved search Sign in Sign up Appearance settings Resetting focus You signed in with another tab or window. Reload to refresh your session. You signed out in another tab or window. Reload to refresh your session. You switched acc … e Work by the copyright owner or by an individual or Legal Entity authorized to submit on behalf of the copyright owner. For the purposes of this definition, "submitted" means any form of electronic, verbal, or written communication sent to the Licensor or its representatives, including but not limited to communication on electronic mailing lists, source code control systems, and issue tracking systems that are managed by, or on behalf of, the Licensor for the purpo … has been received by Licensor and subsequently incorporated within the Work. 2. Grant of Copyright License. Subject to the terms and conditions of this License, each Contributor hereby grants to You a perpetual, worldwide, non-exclusive, no-charge, royalty-free, irrevocable copyright license to reproduce, prepare Derivative Works of, publicly dis
“Great MedTech doesn’t reach patients without the right regulatory pathway.” At MedTech Malta 2025, Kwame Ulmer, Managing Partner at MedTech Impact Partners, shares how early regulatory strategy, FDA insight, and inclusive innovation help MedTech companies move from concept to market with confidence. ▶️ Watch the more such conversation: https://eu1.hubs.ly/H0rpn8v0 📍Next Stop: MedTech World Middle East 2026 | Dubai 🎟️Secure your pass now: https://eu1.hubs.ly/H0rpng70 #MedTech #MedTechWorld #MedTechMalta2025 #RegulatoryStrategy #FDA #MedicalDevices #HealthTech | MedTech World
Omniscope Home Pharma Sports Lifetime Learn Publications Recordings News Contact Log in Immune Portal osSports osLifetime English Español Log in Immune Portal osSports osLifetime See what your immune system is seeing. Explore your immune system to boost performance optimize healthspan engineer therapy Lifetime DISCOVER Sports DISCOVER Pharma DISCOVER Latest news View all Bridging the Gap Between Research and Impact in Barcelona April 29, 2026 Omniscope and barnaclínic+ Launch AI-Driven Immune Decoding to Redefine Sports Medicine April 22, 2026 AYUN and Omniscope Launch AI-Driven "Cellular
Yahoo Inc | Omniscope: Leveraging the power of data and AI to predict the future Skip to main content About Our Team Our Brands Our Technology Business Solutions Overview Yahoo Ads Yahoo DSP Yahoo Search News Newsroom Events Built by Yahoo Careers Contact Us Contact Us magglass Contact Us Search June 26, 2024 | Blog / Insights Omniscope: Leveraging the power of data and AI to predict the future Omniscope is the closest thing to a crystal ball within the Yahoo DSP. Our forecasting tool allows you to project delivery across all channels and formats on the open web, setting your campaigns up for … a million data signals from impression and bid request data every day¹! We then apply predictive AI models to accurately project supply trends for future dates and make these forecasts actionable for advertisers with our DSP forecasting tool, Omniscope. And we put this information in our buyers’ capable hands! Omniscope lets users quickly and easily forecast any targeting setting combination they might want, including audiences, day parting, inventory type, and more.&nb
%PDF-1.4 %���� 468 0 obj > endobj xref 468 54 0000000016 00000 n 0000002395 00000 n 0000001376 00000 n 0000002493 00000 n 0000002528 00000 n 0000002758 00000 n 0000002928 00000 n 0000003079 00000 n 0000003228 00000 n 0000003378 00000 n 0000003568 00000 n 0000003621 00000 n 0000003949 00000 n 0000004473 00000 n 0000004861 00000 n 0000004897 00000 n 0000005539 00000 n 0000006158 00000 n 0000006852 00000 n 0000007972 00000 n 0000008342 00000 n 0000012524 00000 n 0000012919 00000 n 0000013184 00000 n 0000013580 00000 n 0000019201 00000 n 0000019582 00000 n 0000019864 00000 n 0000020433 00000 n 000 … �X|1�43�2��ZZZ������v66�8[[;G;{g������w#�]\=\� > endobj 62 0 obj >stream application/postscript fftt.dvi Adobe Illustrator CS2 2009-04-02T12:28:16+05:30 2009-04-02T12:28:16+05:30 2009-04-02T12:28:16+05:30 156 256 JPEG /9j/4AAQSkZJRgABAgEASABIAAD/7QAsUGhvdG9zaG9wIDMuMAA4QklNA+0AAAAAABAASAAAAAEA
AQBIAAAAAQAB/+4ADkFkb2JlAGTAAAAAAf/bAIQABgQEBAUEBgUFBgkGBQYJCwgGBggLDAoKCwoK
DBAMDAwMDAwQDA4PEA8ODBMTFBQTExwbGxscHx8fHx8fHx8fHwEHBwcNDA0YEBAYGhURFRofHx8f
Hx8fHx8fHx8f … ��EdUH���Ar�8���9�o �|1��ߗ�:�c�M3�?�-i! endstream endobj 76 0 obj >stream application/postscript fftt.dvi Adobe Illustrator CS2 2009-04-02T12:27:36+05:30 2009-04-02T12:27:36+05:30 2009-04-02T12:27:36+05:30 256 248 JPEG /9j/4AAQSkZJRgABAgEASABIAAD/7QAsUGhvdG9zaG9wIDMuMAA4QklNA+0AAAAAABAASAAAAAEA
AQBIAAAAAQAB/+4ADkFkb2JlAGTAAAAAAf/bAIQABgQEBAUEBgUFBgkGBQYJCwgGBggLDAoKCwoK
DBAMDAwMDAwQDA4PEA8ODBMTFBQTExwbGxscHx8fHx8fHx8fHwEHBwcNDA0YEBAYGhURFRofHx8f
Hx8fHx8fHx8f … 1DB4F1FDE11864D9E0611267A81 endstream endobj 77 0 obj > endobj 78 0 obj >stream application/postscript fftt.dvi Adobe Illustrator CS2 2009-04-02T12:00:22+05:30 2009-04-02T12:00:22+05:30 2009-04-02T12:00:22+05:30 256 248 JPEG /9j/4AAQSkZJRgABAgEASABIAAD/7QAsUGhvdG9zaG9wIDMuMAA4QklNA+0AAAAAABAASAAAAAEA
AQBIAAAAAQAB/+4ADkFkb2JlAGTAAAAAAf/bAIQABgQEBAUEBgUFBgkGBQYJCwgGBggLDAoKCwoK
DBAMDAwMDAwQDA4PEA8ODBMTFBQTExwbGxscHx8fHx8fHx8fHwEHBwcNDA0YEBAYGhURFRofHx8f
Hx8fHx8fHx8f … �؊��b�+ϋ�si1������p��>. ��'�0z��`_�5�� endstream endobj 92 0 obj >stream application/postscript fftt.dvi Adobe Illustrator CS2 2009-04-02T12:13:37+05:30 2009-04-02T12:13:37+05:30 2009-04-02T12:13:37+05:30 256 252 JPEG /9j/4AAQSkZJRgABAgEASABIAAD/7QAsUGhvdG9zaG9wIDMuMAA4QklNA+0AAAAAABAASAAAAAEA
AQBIAAAAAQAB/+4ADkFkb2JlAGTAAAAAAf/bAIQABg
Omniscope JavaScript not available Please enable JavaScript Your browser either does not have support for JavaScript, or, more likely, support is turned off. Please enable JavaScript support and reload this page. ✖ You are using an old browser version that may not be compatible with Omniscope. The experience may be degraded and you may experience instabilities or errors. You should use the latest stable version of one of these browsers: Google Chrome Microsoft Edge Mozilla Firefox Opera Recent versions of any other Chromium/Chrome-based browsers. Dismiss
Compare Buzz Radar vs. Omniscope Evo in 2026 News Compare Business Software Thought Leadership Connect Privacy More Add Your Software @slashdot Feedback Opt Out Terms Software Advertising Options News Business Software Thought Leadership Software Audience Intelligence Platforms Buzz Radar vs. Omniscope Evo Compare Buzz Radar vs. Omniscope Evo What’s the difference between Buzz Radar and Omniscope Evo? Compare Buzz Radar vs. Omniscope Evo in 2026 by cost, reviews, features, integrations, deployment, target market, support options, trial offers, training options, years in business, region, and m … continuous innovation, keeping your financial management tools up-to-date. With award-winning customer support, Sage Intacct empowers businesses to streamline 8,453 Ratings Learn More Shoplogix Smart Factory Platform For over two decades, Shoplogix has helped leading manufacturers worldwide unlock hidden production potential by transforming real-time machine and performance data into actionable insights. The platform automatically captures signals like downtime, scrap, and th … ion for Windows and Android devices. The company's easy-to-use and scalable application such as SiteKiosk helps protect the browser and operating system against manipulations and provides 24/7 maintenance-free operation. 25 Ratings Learn More Zendesk Zendesk serves as a robust customer service platform aimed at optimizing support processes and improving the overall experience for customers. With an extensive array of features such as automated AI tools, messaging, live ch … hat effectively illustrate the current status of your brand. Developed with our award-winning proprietary data visualization technology, it offers complete interactivity, seamless customization, and remarkable flexibility. Say goodbye to the tedious hours spent linking your data sources. With just a few clicks, you can securely connect your marketing platforms within a single cohesive environment, allowing our AI to reveal impactful insights presented through engaging visual … onal Display Simulation Models Visual Discovery Embedded Analytics Ad hoc Query Application Development Benchmarking Dashboard Interactive Reports Mobile Reporting Multi-User Collaboration Self Service Analytics Streaming Analytics Visual Workflow Management ETL Data Analysis Data Filtering Data Quality Control Job Scheduling Match & Merge Me
%PDF-1.7 %���� 2377 0 obj > endobj xref 2377 137 0000000016 00000 n 0000006092 00000 n 0000006227 00000 n 0000008074 00000 n 0000008609 00000 n 0000009033 00000 n 0000009540 00000 n 0000009579 00000 n 0000009694 00000 n 0000010173 00000 n 0000010761 00000 n 0000010874 00000 n 0000010999 00000 n 0000011256 00000 n 0000011777 00000 n 0000012028 00000 n 0000013050 00000 n 0000013350 00000 n 0000013719 00000 n 0000013990 00000 n 0000014250 00000 n 0000014877 00000 n 0000016133 00000 n 0000017019 00000 n 0000018236 00000 n 0000019520 00000 n 0000020082 00000 n 0000020347 00000 n 0000020962 00000 n … �&-�Zh(��O��W$��7�p���yӤ{���G/��v�+�� �� endstream endobj 2417 0 obj >stream application/pdf LSN Logo 2022-08-30T13:41:09-04:00 2022-08-30T13:41:09-04:00 2022-08-30T13:41:09-04:00 Adobe Illustrator 26.3 (Windows) uuid:4f5ba327-632d-4d3e-9750-3dbb5ac53375 xmp.did:08a59ab9-3855-0341-99ff-96f16744b3b7 uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf xmp.iid:b8b627b9-63dc-f348-9625-1ed948e71f30 xmp.did:b8b627b9-63dc-f348-9625-1ed948e71f30 uuid:5D20892493BFDB11914A8590D31508C8 d … Adobe PDF library 16.07 endstream endobj 2418 0 obj > endobj 2419 0 obj >stream application/postscript POLSINELLI-TAGLINE (Kelly Ludwig) 2023-12-11T09:48:12-06:00 2023-12-11T09:48:12-06:00 2023-12-11T09:48:12-06:00 Adobe Illustrator 28.0 (Macintosh) xmp.iid:b17b322d-6435-4a3e-a4ae-5611e5ee8738 xmp.did:04150ed5-a00d-4602-a0dc-3bf2c2dce1dc uuid:5D20892493BFDB11914A8590D31508C8 default xmp.iid:8977f143-08ef-46b7-9cc6-fd85c3913a9e xmp.did:273aad7b-7c2c-4234-9706-4fb26a471748 uuid … 1 2023-12-08T08:59:07-06:00 Adobe Illustrator 28.0 (Macintosh) / converted from application/postscript to application/vnd.adobe.illustrator converted from application/postscript to application/vnd.adobe.illustrator converted from application/postscript to application/vnd.adobe.illustrator saved xmp.iid:273aad7b-7c2c-4234-9706-4fb26a471748 2023-12-10T16:10:51-06:00 Adobe Illustrator 28.0 (Macintosh) / converted from application/postscript to application/vnd.adobe.illustrator s … K)�HHODq�C�2�c8�(N0ڀO*�VN�(CIƏ�IC���'��Ns�ի^)+���@F: }F�x�i�p���|�a�M=���rFp)ok� Y�� T�y��6����bh w�U ��P� g����_Lxle�M�v�#�e0�4����m\/���Q�V�0����Ep@ ��@�w���[}�c�WM�x�\Y9�\�xt*���U�鞄k�]Dݝ0ļ�o�3�����ǘ�W�����m�K��4���]Ձ�!H�7~A�� ���1X �X%H�=l��(f�SN 5��B�(e� ,���է,�+: �`�F,G� �Q�K��?2� � ��� :�e�B��=��=�)�����D6= �E��^r
Spin-Offs – Barcelona Institute of Science and Technology – BIST Skip to main content News Newsletter Jobs Events Contact Menu Research Overview Group Leaders Precision Medicine Hub BIST Ignite Programme Chemical Biology Advanced Microscopy Graphene Research & Innovation Sustainable Research Innovation Overview Spin-Offs Catalysers Innovation News Talent Overview Master’s and PhD Students BIST Courses BIST Mentoring Programme WellBIST To the Mothers of Science BIST Career Week 2026 Online Resources Society Overview Outreach Vision and Mission Investiga’m Científiques Qu
Buenavista Equity Partners invierte en la biotecnológica Omniscope | SpainCap LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’s User Agr
Vijay Vaswani on AI in Healthcare at a16z TECH WEEK | Leo Cui, Ph.D., CFA posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you a
Your immune system now has a digital twin for longevity | Holger Heyn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement ,
Gradiant - TRUST has officially started! 🇪🇺 Project... Facebook Log In Gradiant's Post Gradiant June 12 at 1:51 AM · Shared with Public TRUST has officially started! Project partners gathered at Campus Biotech in Geneva for the first consortium meeting, hosted by Mandat International, the project coordinator. Over two days, we aligned on the project vision, work plan and first steps towards developing trustworthy AI-supported services for regulatory compliance. TRUST will combine legal expertise, certification frameworks and user-centred digital tools to make compliance processes safer,
Upgrade & Support Plan | docs.timeinpixels.com docs.timeinpixels.com ⌘ Ctrl k docs.timeinpixels.com Documentation Nobe OmniScope FAQ Requirements Installation License General information Trial License Upgrade & Support Plan Perpetual License Video to Pro upgrade License activation Offline activation Coupon codes Sources Scopes QC Live Pack add-on Features Outputs NDI® StreamDeck Layouts Action Editor Settings & Preferences Troubleshooting Nobe Display FAQ License Color Managed timeline DaVinci Resolve from AppStore NDI® Guide Stereoscopic 3D and VR180 Audio Support Nobe Connect BET … amp; Support Plan is an optional, annual plan that provides owners of OmniScope application updates and priority support. If you purchased OmniScope more than 12 months ago, we encourage you to join the plan and renew your license. Please note: This is not a standard subscription, which requires you to pay every year at a certain time to keep the license active. . Legacy owners of Nobe OmniScope can get current and renew the annual Upgrade & Support plan at any time. Ther
Healthcare Private Placement and M&A Transactions Review Week Ending March 2, 2025 | Silverwood Partners About Us Overview Why Silverwood? Careers Our Location Connect With Us Insights & Analysis Newsletters Intelligence Briefs Events Connect With Us Team All Team Technology Consumer Healthcare Industry Experience Technology Consumer Healthcare Connect With Us Services Mergers & Acquisitions Private Placements Connect With Us Transactions All Transactions Technology Consumer Healthcare Connect With Us Healthcare Private Placement and M&A Transactions Review Week Ending March … mpany raised EUR 15 million of venture funding from European Innovation Council Fund on February 26, 2025. The company is an operator of a biotech business developing innovative approaches for the bypass of direct oral anticoagulants targeting activated factor Xa (FXa DOACs) and inherited coagulation disorders. Chimeron Bio: The company raised $13.7 million of venture funding from undisclosed investors on March 2, 2025. The company is a developer of self-amplifying mRNA vacci … Series A venture funding in a deal led by Chongqing Dian Petrochemical Medical Fund Management on February 24, 2025. Proxima Ventures and Hangzhou Jiurun Investment also participated in the round. The company is a developer of topical drugs designed for applications in ophthalmology, dermatology, and otolaryngology. SIRPant Immunotherapeutics: The company raised $6.5 million of Series A venture funding from BioAdvance Captial and other undisclosed investors on February 25, 2
Checking your browser - reCAPTCHA Checking your browser before accessing pmc.ncbi.nlm.nih.gov ... Click here if you are not automatically redirected after 5 seconds.
Omniscope showcase at Google Cloud Summit 2024 Home Pharma Sports Lifetime Learn Publications Recordings News Contact Log in Immune Portal osSports osLifetime English Español Log in Immune Portal osSports osLifetime Back to Recordings Recordings May 23, 2024 Omniscope showcase at Google Cloud Summit 2024 Omniscope is a partner of Google Cloud and to celebrate our collaboration, Omniscope was featured during the main keynote 'AI for good' at Google Cloud Summit Madrid 2024. Receive updates from Omniscope OVERVIEW Sports Lifetime Pharma Projects Publications COMPANY About us News Caree
On Juneteenth, Recognizing 18 Black Biopharma Industry Leaders - TimmermanReport.com Sorry, you have Javascript Disabled! To see this page as it is meant to appear, please enable your Javascript! Open Menu Traverse Timmerman Traverse for Damon Runyon – Sierras 2026 Past Climbs (2018-2026) The Long Run Podcast About Speaking Podcast Events Team David Shaywitz Alex Harding Pedro Rafael Rosado Steve White In the News Testimonials Contact Subscribe Individual Subscriptions Group Subscriptions Biotech Leaders Get It Traverse Timmerman Traverse for Damon Runyon – Sierras 2026 Past Climbs
How Hydra X Custody is making tokenisation real | Hydra X posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn … ntime Environment (CRE) processed subscriptions and redemptions for a tokenized fund using ISO 20022 messages, the international standard for financial messaging used by Swift. Sep 30, 2025 https://lnkd.in/gJTW6Br9 Chainlink, UBS Advance $100T Fund Industry Tokenization via Swift Workflow coindesk.com Like Comment Share Copy LinkedIn Facebook X To view or add a comment, sign in Ben Grout 9mo Report this post The next frontier in finance is tokenized assets and derivatives Pre
Projects from Omniscope Home Pharma Sports Lifetime Learn Publications Recordings News Contact Log in Immune Portal osSports osLifetime English Español Log in Immune Portal osSports osLifetime Projects Discover the latest projects involving Omniscope. Partners of Current projects with public funding. Tab 1 Tab 2 Tab 3 LIFELUNG Project overview Patient survival after lung transplantation (LTx) for end-stage pulmonary disease is poor (5-year survival rate of 59%) due to ischemia reperfusion injury (IRI) and graft rejection. No therapies are available to prevent IRI, and current immunosuppression … cal LTx cases and established animal models of IRI and rejection, LifeLUNG will apply advanced machine learning and AI-driven deep sequencing to identify key immune factors and gene targets. The latter will be targeted in LifeLUNG with gene therapeutic agents (GTAs) that can be delivered during EVLP to selectively modulate immune responses. Several delivery tools including adeno-associated viral vectors, virus-like particles and lipid nanoparticles, will be tailored to ensure … immune responses and refine xeno-epitope mRNA vaccines. For WP6, Omniscope will apply its osT sequencing technology to analyze TCR sequences from peripheral blood samples collected before and after MTB vaccination in human clinical trial subjects, providing a detailed assessment of adaptive immune system behavior and aiding in the fine-tuning of vaccine designs. Omniscope's unique capability to profile up to 1,000,000 T cells at single-cell resolution offers unprecedente … cal LTx cases and established animal models of IRI and rejection, LifeLUNG will apply advanced machine learning and AI-driven deep sequencing to identify key immune factors and gene targets. The latter will be targeted in LifeLUNG with gene therapeutic agents (GTAs) that can be delivered during EVLP to selectively modulate immune responses. Several delivery tools including adeno-associated viral vectors, virus-like particles and lipid nanoparticles, will be tailored to ensure
Vijay Vaswani - 2024sv - PMWC Precision Medicine World Conference Chat with us , powered by LiveChat Skip to content Chats Contact Speakers Agenda Tickets Menu FULL MENU FULL MENU Register here Rates by JUL. 2 Register here PMWC, Jan 25-27, 2023 PMWC - Silicon valley, ca January 27-29, 2027 Past Event PMWC, Feb 5-7, 2025 PMWC - Silicon valley, ca January 27-29, 2027 Attend Program Schedule Sessions Honorees Speakers Company Competition Showcases Travel Venue Sightseeing Reduced Rates Hotel Flights Exhibits + Map Login / My Account Participate REGISTER TO EXHIBIT Prospectus Attendee Breakdown A … ogin / My Account Participate Register to Exhibit Prospectus Attendee Breakdown Apply to speak Sponsorship Inquiry GET UPDATES ABOUT Mission Testimonial Past Conferences Past Honorees Past Speakers FAQ CONTACT US Menu agenda speakers exhibits Contact us agenda speakers exhibits Contact us BUY TICKETS SAVE $1351 BY JUL. 2 Menu Item #1 Item #1 PMWC - Silicon valley, ca Jan. 27-29, 2027 Pittsburgh, pa sep. 23-24 PMWC - Silicon valley, ca Jan. 27-29, 2027 Register Here Rates by J … tend Program Speakers Travel Exhibits + Map Main Program View your save program Award Reception Speaker gallery Select part speakers Exhibit gallery Part conferences Participate Register to Exhibit Apply to speak Sponsorship Inquiry ABOUT Login / My Account CONTACT US Get Updates Pittsburgh, pa sep. 23-24 Register Here Rates by Attend Program Travel Reduced Rates Exhibits + Map Main Program View your save program Award Reception Paticipate Register to Exibit Apply to speak Sp … he biotechnology industry and finds his passion in improving health through the application of technology. Talk AI-Enabled Immune Repertoire Modeling to Identify Response to Immunotherapy Despite efficacy of immunotherapy, only 20% of patients respond, thus highly heterogeneous patient responses highlight the need for novel predictive strategies that leverage immune cell biomarkers to stratify patients for ICI therapy. Omniscope's deep immune repertoire sequencing and AI demo … tter Facebook Flickr Youtube Open Popup --> × Add Names/PO on Receipt --> Submit Apply to Speak at PMWC Silicon Valley by JUL. 2ND The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details. Name * Email* * Affiliation (Company, Institution, etc) * Inquiry Type * Inquiry Type* Talk/Speaker In
3rd Party Licenses : Omniscope Help Center Skip to main content Omniscope Help Center Home Knowledge base Forums Submit a ticket Login Sign up Home Knowledge base Omniscope T&Cs ... Knowledge base Omniscope T&Cs 3rd Party Licenses All Articles Topics Recent Searches Clear all No recent searches Popular Articles Articles View all Topics View all Tickets View all Sorry! nothing found for 3rd Party Licenses Modified on Fri, 17 Jan, 2025 at 3:37 PM Listing of licensed software included in Omniscope Omniscope includes a number of 3rd-party components, typically called "libraries", embedded … or the purposes of designing, developing, testing, and running Your applets and application("Programs"). 2. Subject to the terms and conditions of this Agreement and restrictions and exceptions set forth in the Software's documentation, You may reproduce and distribute portions of Software identified as a redistributable in the documentation ("Redistributable"), provided that: (a) you distribute Redistributable complete and unmodified and only bundled as part of Your Programs … purposes, the entity performing the evaluation. 2. License Grant and Entitlement. Subject to the terms of your Entitlement, Sun grants you a nonexclusive, nontransferable limited license to use Software for its Permitted Use for the license term. Your Entitlement will specify (a) Software licensed, (b) the Permitted Use, (c) the license term, and (d) the Licensed Units. Additionally, if your Entitlement includes Services, then it will also specify the (e) … selected in your Entitlement, one or more of the following Permitted Uses will apply to your use of Software. Unless you have an Entitlement that expressly permits it, you may not use Software for any of the other Permitted Uses. If you don't have an Entitlement, or if your Entitlement doesn't cover additional software delivered to you, then such software is for your Evaluation Use. (a) Evaluation Use. You may evaluate Software internally for a period of 90 days from your fi … se engineer Software. (e) The terms and conditions of this Agreement will apply to any Software updates, provided to you at Sun's discretion, that replace and/or supplement the original Software, unless such update contains a separate license. (f) You may not publish or provide the results of any benchmark or comparison tests run on Softwar
%PDF-1.7 %���� 28794 0 obj >stream h�L�M�5���驜d8iM@P������ ܞ�)@�}����A�{�~aA��Er���ؙ���y�:믮������7��s����������_�� k��|a��7�x��������������7ۉ;BS���S��� ��)��7�/|'�w���������{�)�^￮/��_�)V�����V~��_w��f��;�|�Uޏ>�l�ܧ3�l}o�y ��f���o���?�l��)�;����PO~���w�����9�l�q���y����k~~����l;V�p}�͝�w�+����l��_�f�z���97�f{u��o�Y��ls�� ����}$��-ם� � ߿b����������;[F�ϰ��2�)��2���VW��o�� f⛭���f{��7���k�lsބo��>�xg���������V�u�� ��|g�u��������V�]_�>�|g���d}��͖� ��l�J��l�J� կB���n��o�O�����j��N�����?w��w���;�w���#����;@z݅5�ҟ���������|��:�E��%}�k����]��Yrϯw�o�~?�w����w����w����w … X��|Ƒ$tԠG�ӄ���H�'�f$81Ҹf��&X��i`BkF�# Jh�Hpb�1Z3 i&�f$ >stream h�D�M�5��e�rfP��ŏٳ B5�C�VZͿhq/��.�]B�/mF�����z�7�~���[��Ư5Kk�������צ��C˶�?���L3��l-��G��zv�?�������u[-ͱ͞��9B_���I9���ܔ?[-��싞�:���7��5-��s�j3~���O6�gі�$�9�/�0�]ߗf���ș��$m�k?M�`�[�˶9rR����/��]���/���9�B3�����"�m�cZKsy��c�?w��Ʋm��~����9X�߾���>�>F����|F���Z^m�k�r�_>�_N:�w��_���6w���!=���c�� ҍ�$�_���[�G^b�㓏� V��k���b�ٿ������y^h�8�0o`n +g����~$�{v�'�#�|��_ls�lF�ߜ�G�����A�� ��m����;>������G�ҧ … :8FFB9771-5A29-4A28-86D5-74056680A25A uuid:c4c8bac9-0ae6-4f55-97a7-1552bf877714 application/pdf endstream endobj 28260 0 obj > endobj 28401 0 obj >stream H��W�n�8}�W��L�EA��ӻ� H#��g0�ز� G��rf��[ԅ�l�36�/�,���n���?��z��+tss�����K�@߮��-���i�{�������t����������yZ�� �������� A�Db���8Ѩ�&�� 哻���?�Z�&���Qb�>/'\`�P�H���LQ��������P�ur� \wEU�.�E�mט�s@��,K̑�k$8� Q�i���"cX�26Pc@:��6���Pt�' M ���'���o�������z�ȩ�Z�W �-l4Y�!�L1N�X���N ���~+cZ�EW��� =�=v�E�Q
Our culture - Omniscope Partners Contact us Contact us About Us Our Culture Our Senior Advisors What We Do How We Work Who We Serve Grid Pattern Grid Blocks Our culture - Many voices, bound by purpose and commitment to a common cause OmniScope Partners is built on a culture that prioritizes deep, long-term relationships, innovative ideas, pragmatic solutions and high-fidelity to a standard of excellence. We proactively seek opportunities to be helpful with an intellectually curious approach and relentless focus on solutions that drive lasting success. We work collaboratively and tirelessly to … r from you Name * Email * Company Phone Message * Subscribe to our mailing list Submit Investment Banking Services and Securities offered through Independent Investment Bankers Corp. a broker-dealer, Member FINRA / SIPC . Omniscope Partners is not affiliated with Independent Investment Bankers Corp. © Omniscope Partners . 2025
News – Baxerna Skip to content HOME ABOUT PARTNERS VIB UGent VUB Institut Pasteur ULB Karolinska Institutet Radboudumc VFI RheaVita Omniscope News Publications CONTACT X News 20 January 2026 Abstract Submission Deadline Extended to January 30th! If you weren’t able to submit your abstract to Next-generation mRNA Vaccines Against Complex Pathogens last week, good news – you now have 10 more days! Submit your abstract for an oral or poster presentation here . 9 January 2026 Abstract Submission Deadline January 16th! Don’t miss the chance to present your work at Next-generation … ration mRNA Vaccines Against Complex Pathogens ! Submissions close in one week. Submit your abstract for an oral or poster presentation here . 20 January 2026 Abstract Submission Deadline Extended to January 30th! If you weren’t able to submit your abstract to Next-generation mRNA Vaccines Against Complex Pathogens last week, good news – you now have 10 more days! Submit your abstract for an oral or poster presentation here . 9 January 2026 Abstract Su … ct for an oral or poster presentation here . 9 January 2026 Abstract Submission Deadline January 16th! Don’t miss the chance to present your work at Next-generation mRNA Vaccines Against Complex Pathogens ! Submissions close in one week. Submit your abstract for an oral or poster presentation here . 4 November 2025 BAXERNA Annual Meeting in Paris On 23-24 October, the BAXERNA consortium gathered at Institut Pasteur for our 2025 Consortium Meeting. A big thank you to all … ns, from antigen discovery to real-world translation. Learn more, register, and submit an abstract on the dedicated event website ! Interested in sponsoring? Check out the sponsorship opportunities here . Organized with support from VIB Training and Conferences. 3 July 2025 BAXERNA conference coming March 2026! We are thrilled to announce the first edition of Next-generation mRNA Vaccines Against Complex Pathogens , taking place 25-26 March 2026 in Leuven, Belgium . This inte … ns, from antigen discovery to real-world translation. Learn more, register, and submit an abstract on the dedicated event website ! Interested in sponsoring? Check out the sponsorship opportunities here . Organized with support from VIB Training and Conferences. 12 December 2024 Conference Season Fall 2024 was packed with conferences for the BAXE
Excited to share a brand new tool is now available in the OmniScope beta: the HectorScope! A 3D waveform scope suggested by colorist Hector Berrebi. Now availabe for beta testing. Questions? Contact us! https://timeinpixels.com/contact/ | Time in Pixels
%PDF-1.4 1 0 obj > endobj 3 0 obj > endobj 4 0 obj [/Pattern /DeviceRGB] endobj 6 0 obj > stream ����JFIF``��C ��C ��1�"�� ���}!1AQa"q2���#B��R��$3br� %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz��������������������������������������������������������������������������� ���w!1AQaq"2�B���� #3R�br� $4�%�&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz��������������������������������������������������������������������������
Omniscope and Fox Chase Cancer Center Announce Research Collaboration to Advance Non-Small Cell Lung Cancer Immunotherapy Development Home Pharma Sports Lifetime Learn Publications Recordings News Contact Log in Immune Portal osSports osLifetime English Español Log in Immune Portal osSports osLifetime Back to News Company News Omniscope and Fox Chase Cancer Center Announce Research Collaboration to Advance Non-Small Cell Lung Cancer Immunotherapy Development Study to analyze T cell dynamics as "living biomarkers" to predict therapeutic response and guide precision medicine decisions.
Breaking News! Barça Innovation Hub X Omniscope featured at The New York Times: Omniscope seeks to support injury-free top performance throughout the season. More specifically, Omniscope’s… | Barça Innovation Hub LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at an
Our Senior Advisors - Omniscope Partners Contact us Contact us About Us Our Culture Our Senior Advisors What We Do How We Work Who We Serve Grid Pattern Grid Blocks Jeff Raphael Founder & Managing Partner Jeff Raphael Founder & Managing Partner LinkedIn Jeff Raphael founded OmniScope Partners with the aim of leveraging his unique combination of experiences in industry and across Wall Street to help guide emerging life sciences enterprises through key inflection points as they seek to advance life-saving technologies and return value to their investors. Prior to founding OmniScope Partn … r from you Name * Email * Company Phone Message * Subscribe to our mailing list Submit Investment Banking Services and Securities offered through Independent Investment Bankers Corp. a broker-dealer, Member FINRA / SIPC . Omniscope Partners is not affiliated with Independent Investment Bankers Corp. © Omniscope Partners . 2025
Solaxa and Alvogen enter into $95M license agreement for the development and commercialization of SLX-100 – Solaxa Inc. Skip to content Home About Us Pipeline News Contact Us Main Menu Solaxa and Alvogen enter into $95M license agreement for the development and commercialization of SLX-100 By Solaxa Inc. / February 23, 2026 Solaxa and Alvogen enter into license agreement for the development and commercialization of SLX-100 for spinocerebellar ataxia type 27B (SCA27B) Alvogen will acquire worldwide rights for SLX-100 for SCA27B and will be responsible for the commercialization of SLX-100 … es by mid-year 2026, with results from the study expected to support a new drug application filing for SCA27B in 2027. Advisors OmniScope Partners acted as exclusive financial advisor and Cooley LLP served as legal advisor to Solaxa on this transaction. About Solaxa Solaxa is a clinical-stage biopharmaceutical public benefit corporation developing treatments that restore nerve function in patients with rare neurodegenerative diseases and acute nerve injuries. The company is d
Omniscope Home Pharma Sports Lifetime Learn Publications Recordings News Contact Log in Immune Portal osSports osLifetime English Español Log in Immune Portal osSports osLifetime Back to Terms and Policies TERMS & POLICIES Privacy Policy Our commitment to you We take the privacy and confidentiality of personal data seriously. We are committed to processing personal data in a lawful, fair and transparent manner, in accordance with applicable data protection laws, and to implementing appropriate measures to protect such data. 1. Overview This Privacy Policy explains how personal data is … in connection with the Website or the Platform. This Privacy Policy does not apply to the independent processing of personal data carried out by third-party clinics, laboratories or healthcare professionals acting under their own responsibility. 2. Who is responsible for your personal data? The controller of the personal data processed through the Website and the Platform is: OMNISCOPE Limited 230, 230 Works Business Centre, Second Floor, Eucharistic Congress Road, M … rom time to time. The updated version will be published on the Website and will apply from the date of its publication. 16. Contact and Data Protection Officer If you have any questions regarding this Privacy Policy or the processing of your personal data, you may contact: Data Protection Officer: [email protected] 17. Artificial Intelligence and Automated Processing At Omniscope, we utilize AI strictly as an assistive tool to deliver insights. Our AI does not make a
TeraOps | Intellectual Property & Industry Research Alliances Skip to main content | Office of the Vice Chancellor for Research Toggle navigation Intellectual Property & Industry Research Alliances Search Terms Submit Search About About Our Office Our Impact Our Team Diversity and Equity Socially Responsible Licensing Startups Launched All Advanced Materials Agriculture BSAC-Affiliated Startup Communications, Information Technology, and Data Processing Electronic Systems and Components Energy Environment Medical Devices Medical Diagnostics Medical Therapeutics Research Tools SBIR/STTR
About us - Omniscope Home Pharma Sports Lifetime Learn Publications Recordings News Contact Log in Immune Portal osSports osLifetime English Español Log in Immune Portal osSports osLifetime Science is we all. We are curious. hopeful. human. driven. Omniscope. Our origin story. It all started with a shift of mindset. What if we can truly see and understand what our immune system is seeing? What if we can leverage our immune system to generate therapeutics, develop diagnostics, and monitor patients? Omniscope was founded in 2020, by a multidisciplinary team of scientists and professionals who wa … in the biotechnology industry and finds his passion in improving health by the application of technology. Vijay Vaswani Co-Founder & CEO Lynnette brings to Omniscope her experience in the financial sector , where she served a diverse client base at Aberdeen Asset Management. These spanned government, private and public financial institutions including Sovereign Wealth Funds, Global Pensions, Central Banks, Insurers as well as Independent intermediates, global banks and o … l Banks, Insurers as well as Independent intermediates, global banks and online fund platforms. Lynnette Ang Co-Founder & Chief Growth Officer Matthew wrote his first program on a 1982 BBC Micro Model B at the age of 4. After more than 20 years of working in all aspects of software , in both startups and multinationals, across a wide spectrum of industries ranging from warehouse robotics to hedge funds, Matthew is still as excited about tech today as he was back then. Mat … joined VHIO. In 2008, he was the recipient of a European Research Council (ERC) grant, became Board member of the European Association of Cancer Research (EACR) and Professor at Universitat Autònoma de Barcelona. In 2012, he founded Mosaic Biomedicals as a spin-off company from his lab. In 2016, he became Secretary General of the EACR. Dr. Ivo Gut Director, Centro Nacional de Análisis Genómico (CNAG) Dr. Heyn leads the Single Cell Genomics Group at the Spanish National Centre
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
EULA : Omniscope Help Center Skip to main content Omniscope Help Center Home Knowledge base Forums Submit a ticket Login Sign up Home Knowledge base Omniscope T&Cs ... Knowledge base Omniscope T&Cs EULA All Articles Topics Recent Searches Clear all No recent searches Popular Articles Articles View all Topics View all Tickets View all Sorry! nothing found for EULA Modified on Tue, 10 Mar at 4:39 PM Omniscope Restricted EULA End user licensing agreement Below is the full text of the standard Omniscope End-User License Agreement (EULA). Software Support is provided according to the terms … tual property laws and treaties. The Software Product is licensed, not sold. 1. GRANT OF LICENSE. This Section of the EULA describes Your general rights to install and use the Software Product. The license rights described in this Section are subject to all other terms and conditions of this EULA. General License Grant to Install and Use Software Product: You may install and use one copy of the Software Product on a single computer, device, workstation, terminal, or other dig … nstallations will be fully-functional free Viewer Editions. Alternative License Grant for Storage/Network Use: As an alternative to the rights granted in the previous section, You may install a copy of the Software Product on one storage Device, such as a network server, and allow individuals within Your business or enterprise to access and use the Software Product from other Devices over a private network, provided that You acquire and dedicate a license for the storage Devi … e Product may not be used concurrently on different Devices. Additional License Grant for Media Elements. The Software Product may include certain photographs, maps, clip art, animations, sounds, music and video clips (together "Media Elements"). If so, the following terms describe Your rights to the Media Elements: You are not licensed to do any of the following: • You may not sell, license or distribute copies of the Media Elements on a stand-alone basis or as part of any c … tion for sale or distribution of any other computer program. This EULA does not grant a license or right to use the Software Product on any computer or computer system other than YOURS or to use the same Software Product license on different virtual or physical machines at more than one network or physical location. Reservation of Rights. All rig
Recordings from Omniscope Inicio Pharma Sports Lifetime Aprender Publicaciones Grabaciones Noticias Contacto Acceder Immune Portal osSports osLifetime English Español Log in Immune Portal osSports osLifetime Grabaciones Mira a Omniscope en acción. SIGUIENTE Omniscope and barnaclínic+ Launch AI-Driven Immune Decoding to Redefine Sports Medicine Omniscope decodes immune data to personalize performance and recovery strategies for athletes. Partnering with barnaclínic+, we’re delivering these insights to active individuals while supporting public healthcare. BBC Sport & Omniscope: The Biologic … Vijay Vaswani discusses Omniscope's osLifetime platform, highlighting its application to monitor longevity interventions. The Immune System as a Natural Sensor for Health and Aging At the Biology of Aging Conference (GRC), CSO and Cofounder Holger Heyn discusses Omniscope's osLifetime platform, highlighting its application to monitor health and aging. Receive updates from Omniscope GENERAL Sports Lifetime Pharma Proyectos Publicaciones EMPRESA Sobre nosotros Notici
AWS Marketplace: Omniscope Evo Agent Mode English Sign in or Create a new account About Categories Delivery Methods Solutions Resources Become a Channel Partner Sell in AWS Marketplace Amazon Web Services Home Help AWS Marketplace ... Data Analytics Amazon Machine Image (AMI) Omniscope Evo AWS Marketplace Data Analytics Amazon Machine Image (AMI) Omniscope Evo Omniscope Evo Info Sold by: Visokio Deployed on AWS AWS Free Tier Omniscope Evo is a all-in-one self-service BI software for no-code data prep, analytics and reporting, on any device with any data 4.7 (23) View purchase options Overview … es Pricing Legal Usage Resources Support Reviews Overview Try agent mode Create proposal Ask question Product video Omniscope Evo: complete and extensible BI software for data processing, analytics and reporting. A smart experience on any device, Omniscope is the data sensemaking tool for every step of your data journey Omniscope is: No-code Data Prep, ETL: build workflows to load, stream, blend and transform any data. Analytics: leverage machine learning, extract insights an … ect the status of the external license. Additional AWS infrastructure costs may apply. Use the AWS Pricing Calculator to estimate your infrastructure costs. Vendor refund policy https://help.visokio.com/support/solutions/articles/42000035930-eula How can we make this page better? Tell us how we can improve this page, or report an issue with this product. Give us feedback Report a problem with this product or seller Legal Vendor terms and conditions Upon subscribing to this pr … & Marketing Data Telecommunications Data DevOps Agile Lifecycle Management Application Development Application Servers Application Stacks Continuous Integration and Continuous Delivery Infrastructure as Code Issue & Bug Tracking Log Analysis Monitoring Source Control Testing Industries Automotive Education & Research Energy Financial Services Healthcare & Life Sciences Industrial Media & Entertainment Infrastructure Software Backup & Recovery Data Ana … l in AWS Marketplace Management Portal Sign up as a Seller Seller Guide Partner Application Partner Success Stories About What is AWS Marketplace? Why AWS Marketplace? Get started in AWS Marketplace Procurement options Cost management tools Governance & control features Free trials Sell in AWS Marketplace Featured Categories SaaS Subscription
BBC Sport & Omniscope: The Biological Revolution Redefining Football’s Future Home Pharma Sports Lifetime Learn Publications Recordings News Contact Log in Immune Portal osSports osLifetime English Español Log in Immune Portal osSports osLifetime Back to Recordings Recordings April 1, 2026 BBC Sport & Omniscope: The Biological Revolution Redefining Football’s Future BBC Sport explores how Omniscope is revolutionizing football by shifting focus from physical stats to internal biology. Using AI and immune system mapping, elite clubs like FC Barcelona can now predict fatigue and prevent i
Omniscope Classic Licensing Terms : Omniscope Help Center Skip to main content Omniscope Help Center Home Knowledge base Forums Submit a ticket Login Sign up Home Knowledge base Omniscope T&Cs ... Knowledge base Omniscope T&Cs Omniscope Classic Licensing Terms All Articles Topics Recent Searches Clear all No recent searches Popular Articles Articles View all Topics View all Tickets View all Sorry! nothing found for Omniscope Classic Licensing Terms Modified on Tue, 18 Aug, 2020 at 9:35 AM Omniscope licensing terms and full-text agreements Free Viewers are available to all and are perpe
Head of Operations, Laboratory - Spain Inicio Pharma Sports Lifetime Aprender Publicaciones Grabaciones Noticias Contacto Acceder Immune Portal osSports osLifetime English Español Log in Immune Portal osSports osLifetime Back to Careers Careers Head of Operations, Laboratory - Spain Job description Omniscope is a TechBio company that is decoding the immune system at an unprecedented resolution. Our proprietary immune profiling technology enables transformative insights into immune health, aging, and performance. We operate globally with a distributed team and are supported by top investors and … o believes in rewarding employees with equity. Employment type Full time Please apply to this job via Linkedin. Apply Receive updates from Omniscope GENERAL Sports Lifetime Pharma Proyectos Publicaciones EMPRESA Sobre nosotros Noticias Empleo FAQ Contacto TÉRMINOS Y POLÍTICAS Política de privacidad Otras políticas Configuración de cookies REDES SOCIALES Descubre lo que tu sistema inmunitario está viendo. Suscríbete © 2025 omniscope
Laboratory Technician - Spain Home Pharma Sports Lifetime Learn Publications Recordings News Contact Log in Immune Portal osSports osLifetime English Español Log in Immune Portal osSports osLifetime Back to Careers Careers Laboratory Technician - Spain Job description Omniscope is a TechBio company that is decoding the immune system at an unprecedented resolution. Our proprietary immune profiling technology enables transformative insights into immune health, aging, and performance. We operate globally with a distributed team and are supported by top investors and public funding partners across … ll adhere to Spanish labor laws regarding rest periods and compensation. Please apply to this job via Linkedin. Apply Receive updates from Omniscope OVERVIEW Sports Lifetime Pharma Projects Publications COMPANY About us News Careers FAQ Contact TERMS & POLICIES Privacy policy Other policies Cookie settings Social Media See what your immune system is seeing. Subscribe © 2025 omniscope
Careers at Omniscope Home Pharma Sports Lifetime Learn Publications Recordings News Contact Log in Immune Portal osSports osLifetime English Español Log in Immune Portal osSports osLifetime Careers The people at Omniscope are on a brave and bold mission to help people. All people. Why Omniscope? We go deep, to reveal and unravel complexity, to put science in service of humanity. We believe in democratizing access to diagnostics and therapeutics to address global health inequities. We disrupt by inclusion, through ecosystemic collaboration, and are determined to make a lasting impact in society
Careers at Omniscope Home Pharma Sports Lifetime Learn Publications Recordings News Contact Log in Immune Portal osSports osLifetime English Español Log in Immune Portal osSports osLifetime Careers The people at Omniscope are on a brave and bold mission to help people. All people. Why Omniscope? We go deep, to reveal and unravel complexity, to put science in service of humanity. We believe in democratizing access to diagnostics and therapeutics to address global health inequities. We disrupt by inclusion, through ecosystemic collaboration, and are determined to make a lasting impact in society